| Veronica Carol Blair, CNM WHNP | |
|
96 E Kimballs Ln Ste 202, Draper, UT 84020-5021 | |
| (801) 523-3053 | |
| (801) 523-3059 |
| Full Name | Veronica Carol Blair |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 16 Years |
| Location | 96 E Kimballs Ln Ste 202, Draper, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174774301 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 2863704402 (Utah) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Mark's Gynecology Oncology Care Llc | 4486736279 | 15 |
News Archive
A recent study conducted by the EU Horizon 2020-funded ParaFishControl project aimed to demonstrate the absence of zoonotic parasitic worms in European farmed fish, specifically in gilthead sea bream, European sea bass, turbot, Atlantic salmon, rainbow trout and common carp.
In a commentary published in the American Journal of Kidney Diseases, public health researchers suggest adjustments to recently proposed rule changes on how Medicare pays for dialysis services.
RF Monolithics, Inc. a leader in machine-to-machine (M2M) wireless communications announced today that it has secured a multi-year agreement with a major medical equipment manufacturer for its ultra-low power short-range radio, the Virtual Wire™ transceiver.
Anacor Pharmaceuticals announced today that it has completed the enrollment of approximately 600 patients in the second of its two Phase 3 trials of tavaborole, a topical anti-fungal product candidate for the treatment of onychomycosis, a fungal infection of the nail and nail bed that affects approximately 35 million people in the United States.
› Verified 7 days ago
| Entity Name | St Mark's Gynecology Oncology Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053593921 PECOS PAC ID: 4486736279 Enrollment ID: O20080201000232 |
News Archive
A recent study conducted by the EU Horizon 2020-funded ParaFishControl project aimed to demonstrate the absence of zoonotic parasitic worms in European farmed fish, specifically in gilthead sea bream, European sea bass, turbot, Atlantic salmon, rainbow trout and common carp.
In a commentary published in the American Journal of Kidney Diseases, public health researchers suggest adjustments to recently proposed rule changes on how Medicare pays for dialysis services.
RF Monolithics, Inc. a leader in machine-to-machine (M2M) wireless communications announced today that it has secured a multi-year agreement with a major medical equipment manufacturer for its ultra-low power short-range radio, the Virtual Wire™ transceiver.
Anacor Pharmaceuticals announced today that it has completed the enrollment of approximately 600 patients in the second of its two Phase 3 trials of tavaborole, a topical anti-fungal product candidate for the treatment of onychomycosis, a fungal infection of the nail and nail bed that affects approximately 35 million people in the United States.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Veronica Carol Blair, CNM WHNP Po Box 198546, Atlanta, GA 30384-8546 Ph: () - | Veronica Carol Blair, CNM WHNP 96 E Kimballs Ln Ste 202, Draper, UT 84020-5021 Ph: (801) 523-3053 |
News Archive
A recent study conducted by the EU Horizon 2020-funded ParaFishControl project aimed to demonstrate the absence of zoonotic parasitic worms in European farmed fish, specifically in gilthead sea bream, European sea bass, turbot, Atlantic salmon, rainbow trout and common carp.
In a commentary published in the American Journal of Kidney Diseases, public health researchers suggest adjustments to recently proposed rule changes on how Medicare pays for dialysis services.
RF Monolithics, Inc. a leader in machine-to-machine (M2M) wireless communications announced today that it has secured a multi-year agreement with a major medical equipment manufacturer for its ultra-low power short-range radio, the Virtual Wire™ transceiver.
Anacor Pharmaceuticals announced today that it has completed the enrollment of approximately 600 patients in the second of its two Phase 3 trials of tavaborole, a topical anti-fungal product candidate for the treatment of onychomycosis, a fungal infection of the nail and nail bed that affects approximately 35 million people in the United States.
› Verified 7 days ago
Kimberly L Stuck, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 96 E Kimballs Ln Ste 202, Draper, UT 84020 Phone: 801-523-3053 Fax: 801-523-3059 | |
Michelle Grubb, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 96 E Kimballs Ln Ste 202, Draper, UT 84020 Phone: 801-523-3053 Fax: 801-523-3059 | |
Nathan Matthew Morris, Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 96 E Kimballs Ln Ste 202, Draper, UT 84020 Phone: 801-523-3053 Fax: 801-523-3059 |